FUJI PHARMA CO., LTD. Toevoegen aan een lijst
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 1.477 JPY | -0,40% |
|
-3,02% | -15,07% |
Vakgebied
Aantal werknemers: 1 621
Verkoop per activiteit
| JPY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
|---|---|---|---|---|---|
Product - Hormones
39,3
%
| 12 073 | 34,1 % | 16 047 | 39,3 % | +32,92% |
Product - Others
24,1
%
| 9 032 | 25,5 % | 9 846 | 24,1 % | +9,01% |
Product - Diagnostic Agent
18,8
%
| 7 447 | 21,0 % | 7 672 | 18,8 % | +3,02% |
Product - Metabolic Drugs
5,0
%
| 1 486 | 4,2 % | 2 056 | 5,0 % | +38,36% |
Merchandise - Others
3,4
%
| 930 | 2,6 % | 1 409 | 3,4 % | +51,51% |
Product - Tissue Cell Function Drug
2,5
%
| 948 | 2,7 % | 1 010 | 2,5 % | +6,54% |
Merchandise - Hormones
2,3
%
| 1 227 | 3,5 % | 925 | 2,3 % | -24,61% |
Product - Nervous System and Sensory Organ Agents
1,8
%
| 924 | 2,6 % | 749 | 1,8 % | -18,94% |
Product - Antibiotics and Chemotherapeutic Agents
1,5
%
| 651 | 1,8 % | 630 | 1,5 % | -3,23% |
Product - Cardiovascular Drugs
1,0
%
| 553 | 1,6 % | 409 | 1,0 % | -26,04% |
Merchandise - In-vitro Diagnostics Drugs
0,3
%
| 149 | 0,4 % | 130 | 0,3 % | -12,75% |
Verkoop per regio
| JPY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
|---|---|---|---|---|---|
Japan
100,0
%
| 35 426 | 100,0 % | 40 889 | 100,0 % | +15,42% |
Managers
| Managers | Titel | Leeftijd | Van |
|---|---|---|---|
Takayuki Iwai
PSD | President | 60 | 01-12-06 |
Hirofumi Imai
CHM | Chairman | 60 | 01-04-87 |
Hiroshi Uji
ADM | Chief Administrative Officer | - | - |
Toyoyuki Kamide
BRD | Director/Board Member | 59 | 01-04-00 |
Takanori Matsuo
SAM | Sales & Marketing | - | - |
Shuhei Morita
PRN | Corporate Officer/Principal | - | - |
Seiichi Inoue
AUD | Comptroller/Controller/Auditor | 65 | 01-04-14 |
| Corporate Officer/Principal | 53 | 01-04-94 |
Besturend
| Besturend | Titel | Leeftijd | Van |
|---|---|---|---|
Vilhelm Wessman
BRD | Director/Board Member | 54 | 01-11-18 |
Keiji Hirai
BRD | Director/Board Member | 74 | 01-12-16 |
| Director/Board Member | 71 | 01-12-17 | |
Hirofumi Imai
CHM | Chairman | 60 | 01-04-87 |
Toyoyuki Kamide
BRD | Director/Board Member | 59 | 01-04-00 |
Tadahiro Kozawa
BRD | Director/Board Member | 74 | 01-10-93 |
| Corporate Officer/Principal | 53 | 01-04-94 | |
Seiichi Inoue
AUD | Comptroller/Controller/Auditor | 65 | 01-04-14 |
Takayuki Iwai
PSD | President | 60 | 01-12-06 |
Yukiko Araki
BRD | Director/Board Member | 63 | 01-12-20 |
Aandelenklasse
| Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
|---|---|---|---|---|---|
| Aandeel A | 0 | 24 753 800 | 12 260 585 ( 49,53 %) | 441 500 ( 1,784 %) | 49,53 % |
Participaties
| Naam | Aandelen | % | Totale waarde |
|---|---|---|---|
ALVOTECH 1.68% | 4 475 691 | 1.68% | 61 093 182 $ |
| 4 913 220 | 1.85% | 48 736 882 $ | |
FUJI PHARMA CO., LTD. 1.75% | 433 400 | 1.75% | 4 379 030 $ |
Bedrijfsgegevens
Fuji Pharma Co., Ltd.
Seito Kaikan, 6/F 5-7 Sanban-cho
102-0075, Tokyo
+81 3 3556 3344
http://www.fujipharma.jp
Sector
Verkoop per activiteit
Verkoop per regio
Trading rating
Beleggingsrating
ESG Refinitiv
Verkoop
Koop
Gemiddeld advies
Kopen
Aantal analisten
3
Laatste slotkoers
1.477
JPY
Gemiddelde koersdoel
2.057
JPY
Spread / Gemiddelde doel
+39,25%
Herzieningen van WPA
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| -15,07% | 229 mln. | |
| +38,51% | 727 mld. | |
| +33,05% | 599 mld. | |
| -6,23% | 354 mld. | |
| +18,78% | 328 mld. | |
| +1,35% | 277 mld. | |
| +16,00% | 243 mld. | |
| +8,09% | 205 mld. | |
| -5,77% | 203 mld. | |
| +6,19% | 164 mld. |
- Beurs
- Aandelen
- Koers 4554
- Onderneming Fuji Pharma Co., Ltd.